Production (Stage)
eXoZymes, Inc.
EXOZ
$12.81
-$0.34-2.59%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -84.08% | -67.12% | -218.17% | -663.90% | -318.12% |
| Total Depreciation and Amortization | 12.26% | 14.58% | 38.63% | 54.42% | 42.40% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 123.49% | 74.38% | 70.52% | 828.84% | 229.08% |
| Change in Net Operating Assets | -68.63% | -5,556.10% | 188.80% | -9,090.75% | 1,248.47% |
| Cash from Operations | -503.09% | -628.65% | -1,492.65% | -2,122.24% | 212.75% |
| Capital Expenditure | 79.17% | -91.80% | 100.00% | -160.14% | -561.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 100.00% | -- |
| Cash from Investing | 78.23% | -91.80% | 121.73% | -1.36% | -532.89% |
| Total Debt Issued | -- | 277.40% | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 5,002.04% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 52.68% | 3,075.94% | 13.86% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2,653.49% | 2,424.85% | -77.66% | 129.42% | 117.40% |